» Articles » PMID: 34746706

Renal Subcapsular Delivery of PGE Promotes Kidney Repair by Activating Endogenous Sox9 Stem Cells

Overview
Journal iScience
Publisher Cell Press
Date 2021 Nov 8
PMID 34746706
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Prostaglandin E (PGE) has recently been recognized to play a role in immune regulation and tissue regeneration. However, the short half-life of PGE limits its clinical application. Improving the delivery of PGE specifically to the target organ with a prolonged release method is highly desirable. Taking advantage of the adequate space and proximity of the renal parenchyma, renal subcapsular delivery allows minimally invasive and effective delivery to the entire kidney. Here, we report that by covalently cross-linking it to a collagen matrix, PGE exhibits an adequate long-term presence in the kidney with extensive intraparenchymal penetration through renal subcapsular delivery and significantly improves kidney function. Sox9 cell lineage tracing with intravital microscopy revealed that PGE could activate the endogenous renal progenitor Sox9 cells through the Yap signaling pathway. Our results highlight the prospects of utilizing renal subcapsular-based drug delivery and facilitate new applications of PGE-releasing matrices for regenerative therapy.

Citing Articles

Engineered extracellular vesicles promote the repair of acute kidney injury by modulating regulatory T cells and the immune microenvironment.

Xie L, Zhang K, Pan K, Su X, Zhao X, Li R J Transl Med. 2025; 23(1):304.

PMID: 40065372 PMC: 11895318. DOI: 10.1186/s12967-025-06268-x.


Gene therapy and kidney diseases.

Tavakolidakhrabadi N, Ding W, Saleem M, Welsh G, May C Mol Ther Methods Clin Dev. 2024; 32(4):101333.

PMID: 39434922 PMC: 11492605. DOI: 10.1016/j.omtm.2024.101333.


Longitudinal intravital microscopy of the mouse kidney: inflammatory responses to abdominal imaging windows.

Martinez M, Walsh J, Kamocka M, Lee H, Dunn K Am J Physiol Renal Physiol. 2024; 327(5):F845-F868.

PMID: 39323386 PMC: 11563595. DOI: 10.1152/ajprenal.00071.2024.


Comparative study of systemic and local delivery of mesenchymal stromal cells for the treatment of chronic kidney disease.

Gregersen E, Kresse J, Atay J, Boysen A, Nejsum P, Eijken M Front Cell Dev Biol. 2024; 12:1456416.

PMID: 39234562 PMC: 11373351. DOI: 10.3389/fcell.2024.1456416.


Forkhead Box Protein K1 Promotes Chronic Kidney Disease by Driving Glycolysis in Tubular Epithelial Cells.

Zhang L, Tian M, Zhang M, Li C, Wang X, Long Y Adv Sci (Weinh). 2024; 11(36):e2405325.

PMID: 39083268 PMC: 11423168. DOI: 10.1002/advs.202405325.


References
1.
Martinez-Colon G, Moore B . Prostaglandin E as a Regulator of Immunity to Pathogens. Pharmacol Ther. 2017; 185:135-146. PMC: 5898978. DOI: 10.1016/j.pharmthera.2017.12.008. View

2.
Boulch M, Grandjean C, Cazaux M, Bousso P . Tumor Immunosurveillance and Immunotherapies: A Fresh Look from Intravital Imaging. Trends Immunol. 2019; 40(11):1022-1034. DOI: 10.1016/j.it.2019.09.002. View

3.
Xiao C, Yuhki K, Hara A, Fujino T, Kuriyama S, Yamada T . Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation. 2004; 109(20):2462-8. DOI: 10.1161/01.CIR.0000128046.54681.97. View

4.
Hsueh Y, Wu J, Yu C, Wu K, Hsieh P . Prostaglandin E₂ promotes post-infarction cardiomyocyte replenishment by endogenous stem cells. EMBO Mol Med. 2014; 6(4):496-503. PMC: 3992076. DOI: 10.1002/emmm.201303687. View

5.
Feng G, Zhang J, Li Y, Nie Y, Zhu D, Wang R . IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI. J Am Soc Nephrol. 2016; 27(8):2357-69. PMC: 4978042. DOI: 10.1681/ASN.2015050578. View